Sharon Laboratories and DEINOVE enter into MoU
We are excited to share Sharon Laboratories has signed Memorandum of Understanding (MoU) with DEINOVE, a French biotech company that owns a disruptive technology.
Under this agreement, Sharon Laboratories and DEINOVE will develop and bring into the market an exclusive range of bio-based ingredients for personal care.
This strategic collaborative R&D program will benefit from DEINOVE's accumulated expertise in leveraging the properties of its wide collection of rare microorganisms and biotechnology platform, building on Sharon Laboratories 40 years of experience in the personal care segment, and substantial success in bringing effective, safe, scientifically advanced and consumer-driven solutions to the market.
"We are excited to enter this new field of bio-based actives, which we believe is the future of the cosmetic industry. The global cosmetic market is seeking natural solutions, this collaboration will lead us to the next generation of ingredients which are not only safe and sustainable, but promote health and wellbeing", says Ari Melamud, CEO of Sharon Laboratories.
"We are glad to provide Sharon Laboratories with our breakthrough technology and strong scientific know-how while benefiting from their market knowledge and extensive distribution network. This complementary collaboration has everything it takes to offer tomorrow’s cosmetic market needs”, adds Charles Woler, CEO of DEINOVE."